The estimated Net Worth of Mark A Kay is at least $158 Thousand dollars as of 1 January 2021. Mark Kay owns over 2,199 units of ContextLogic Inc stock worth over $11,765 and over the last 6 years he sold LOGC stock worth over $0. In addition, he makes $146,383 as Independent Director at ContextLogic Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mark Kay LOGC stock SEC Form 4 insiders trading
Mark has made over 1 trades of the ContextLogic Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 2,199 units of LOGC stock worth $11,765 on 1 January 2021.
The largest trade he's ever made was exercising 2,199 units of ContextLogic Inc stock on 1 January 2021 worth over $11,765. On average, Mark trades about 275 units every 0 days since 2018. As of 1 January 2021 he still owns at least 2,199 units of ContextLogic Inc stock.
You can see the complete history of Mark Kay stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Kay biography
Dr. Mark A. Kay M.D., Ph.D. serves as Independent Director of the Company. Dr. Kay is the Dennis Farrey Family Professor in Pediatrics, and a professor of genetics at Stanford University School of Medicine, where he heads the division of human gene therapy. Dr. Kay moved from the University of Washington to Stanford in 1998, where he has been on the faculty since that time. A founder of the American Society of Gene and Cell Therapy, Dr. Kay served as the society’s president from 2005 to 2006. Dr. Kay also serves as a member of the board of directors of Genevant Sciences. He holds a B.S. in physical science from Michigan State University and an M.D. and Ph.D. from Case Western Reserve University. Kay is qualified to serve on our board of directors due to his significant expertise regarding our technology platform and his long-standing reputation in the field of gene therapy.
What is the salary of Mark Kay?
As the Independent Director of ContextLogic Inc, the total compensation of Mark Kay at ContextLogic Inc is $146,383. There are 5 executives at ContextLogic Inc getting paid more, with Frederic Chereau M.B.A. having the highest compensation of $677,202.
How old is Mark Kay?
Mark Kay is 62, he's been the Independent Director of ContextLogic Inc since 2016. There are 3 older and 14 younger executives at ContextLogic Inc. The oldest executive at ContextLogic Inc is Richard Moscicki, 68, who is the Independent Director.
What's Mark Kay's mailing address?
Mark's mailing address filed with the SEC is C/O LOGICBIO THERAPEUTICS, INC., 65 HAYDEN AVE, FLOOR 2, LEXINGTON, MA, 02421.
Insiders trading at ContextLogic Inc
Over the last 6 years, insiders at ContextLogic Inc have traded over $4,601,420 worth of ContextLogic Inc stock and bought 6,882,964 units worth $56,977,784 . The most active insiders traders include Tomer Kariv, Advisors Llc Orbi Med Capit..., and Mark J Enyedy. On average, ContextLogic Inc executives and independent directors trade stock every 97 days with the average trade being worth of $1,869,237. The most recent stock trade was executed by Brett Just on 15 August 2024, trading 6,465 units of LOGC stock currently worth $34,588.
What does ContextLogic Inc do?
wish is a mobile e-commerce platform that connects hundreds of millions of consumers with the widest selection of products delivered directly to their doors. our mission is to provide everyone access to the most affordable and convenient shopping experience on the planet. wish supports 500,000 merchant partners as well as over 300 million users who rate wish the best mobile shopping app on the ios and android platforms. founded in 2011, wish has raised over a billion dollars from top funds, such as temasek, dst, ggv capital, founders fund, and jerry yang’s ame cloud. wish is headquartered in san francisco, with additional offices in shanghai, toronto, dublin, amsterdam, and more.
What does ContextLogic Inc's logo look like?
Complete history of Mark Kay stock trades at ContextLogic Inc
ContextLogic Inc executives and stock owners
ContextLogic Inc executives and other stock owners filed with the SEC include:
-
Frederic Chereau M.B.A.,
Pres, CEO & Director -
Seokho Yoon,
-
Frederic Chereau,
President, Chief Executive Officer, Director -
Dr. Daniel J. Gruskin M.D.,
Chief Medical Officer -
Mariana Nacht Ph.D.,
Chief Scientific Officer -
Mark Kay,
Independent Director -
Dr. Mark A. Kay M.D., Ph.D.,
Co-Founder, Chairman of Scientific Advisory Board & Independent Director -
Michael Wyzga,
Independent Director -
Erez Chimovits,
Independent Director -
Leon Chen,
Independent Director -
Richard Moscicki,
Independent Director -
Daniel O'Connell,
Independent Director -
Kyle Chiang,
Chief Operating Officer -
Daniel Gruskin,
Interim Head of Clinical Development -
Brian Luque,
Associate Director, Investor Relations -
Mark Enyedy,
Independent Director -
Matthias Jaffe,
Chief Financial Officer -
Grace Lochhead,
VP & Head of HR -
Dr. Leszek Lisowski M.B.A., Ph.D.,
Co-Founder & Member of Scientific Advisory Board -
Matthias B. Jaffe,
Consultant -
Andrea Paul,
Gen. Counsel & Corp. Sec. -
Dr. Matthias Hebben,
Global VP & Head of Technology Devel. -
Cecilia Jones,
Chief Financial Officer -
Dr. Adi Barzel Ph.D.,
Co-Founder -
Dr. Leszek Lisowski Ph.D.,
Co-Founder -
Mariana Nacht,
Chief Scientific Officer -
Brett Just,
Chief Financial Officer -
Bioscience Plc Arix Bioscie...,
-
Tomer Kariv,
Director -
Sofia Ioannidou,
Director -
Thomas Wilton,
Chief Business Officer -
Dean Falb,
Chief Scientific Officer -
Advisors Llc Orbi Med Capit...,
-
Kenneth Huttner,
SVP, Head of Clinical Dev. -
Advisors Llc Orbi Med Capit...,
-
Cecilia Jones,
Chief Financial Officer -
Daphne Karydas,
Director -
Jeff Goater,
Director -
Susan Kahn,
Director -
Andrea Paul,
General Counsel and Secretary -
Joanna Forster,
General Counsel & CCO